Severe Acute Respiratory Syndrome

Respiratory
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Vaccine
1100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Genentech
GenentechCA - Oceanside
1 program
1
Alteplase 50 MG [Activase]Phase 21 trial
Active Trials
NCT04357730Completed50Est. Sep 2021
C
CureVacGermany - Tübingen
1 program
1
CVnCoV VaccinePhase 1Vaccine1 trial
Active Trials
NCT04449276CompletedEst. Dec 2021
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Collection of Convalescent SARS Plasma by ApheresisN/A1 trial
Active Trials
NCT00342524CompletedEst. Feb 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GenentechAlteplase 50 MG [Activase]
CureVacCVnCoV Vaccine
Allergy TherapeuticsCollection of Convalescent SARS Plasma by Apheresis

Clinical Trials (3)

Total enrollment: 50 patients across 3 trials

NCT04357730GenentechAlteplase 50 MG [Activase]

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

Start: May 2020Est. completion: Sep 202150 patients
Phase 2Completed
NCT04449276CureVacCVnCoV Vaccine

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Start: Jun 2020Est. completion: Dec 2021
Phase 1Completed
NCT00342524Allergy TherapeuticsCollection of Convalescent SARS Plasma by Apheresis

Collection of Convalescent SARS Plasma by Apheresis

Start: Jul 2005Est. completion: Feb 2007
N/ACompleted

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space